Douglas J. Swirsky, Director at Cellectar Biosciences, Inc. (CLRB), bought 25,000 shares at $1.04 ($26K) on 2021-09-14, disclosed to the SEC on 2021-09-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| MXCT | SELL | 2025-03-20 | $22K | — | Filing → |
| RNN | BUY | 2019-01-30 | $32K | — | Filing → |
| GNVC | BUY | 2016-09-16 | $5K | — | Filing → |